✦ LIBER ✦

Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma (aBCC): 24-month update of the pivotal ERIVANCE BCC study

Book ID: 122326967
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 45 KB
Volume: 70
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2014.01.570

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Pivotal Multicenter Trial Evaluating E

A Pivotal Multicenter Trial Evaluating Efficacy and Safety of the Hedgehog Pathway Inhibitor (HPI) Vismodegib in Patients With Advanced Basal Cell Carcinoma (BCC)

✍ L. Dirix; M.R. Migden; A.E. Oro; A. Hauschild; K. Lewis; A.B. Mueller; R. Yauch; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB

A pivotal multicenter trial evaluating e

A pivotal multicenter trial evaluating efficacy and safety of the hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with advanced basal cell carcinoma

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Long-term efficacy and safety of zoledro

Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors : A randomized, Phase III, double-blind, placebo-controlled trial

✍ Lee S. Rosen; David Gordon; N. Simon Tchekmedyian; Ronald Yanagihara; Vera Hirsh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views